New Key Statistics Module, Z-Score and F-Score
NAS:RNA Key Ratios
Market Cap $ M | 1,812.02 |
Enterprise Value $ M | 1,251.24 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.60 |
Price/Sales | 177.51 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 9.00 |
EPS (TTM) $ | -2.91 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -49.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.43 |
EV-to-EBITDA | -5.47 |
PEG | -- |
Shares Outstanding M | 79.72 |
Net Margin (%) | -2,219.87 |
Operating Margin % | -2,464.41 |
Pre-tax Margin (%) | -2,219.87 |
Quick Ratio | 7.58 |
Current Ratio | 7.58 |
ROA % (ttm) | -34.62 |
ROE % (ttm) | -39.09 |
ROIC % (ttm) | -607.36 |
Dividend Yield % | -- |
Altman Z-Score | 7.27 |
Piotroski F-Score | 3.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | Y |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
RNA Number of Guru Trades
RNA Volume of Guru Trades
Gurus Latest Trades with NAS:RNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Avidity Biosciences Inc Insider Transactions
No Available Data
News about NAS:RNA
Total 0- 1